{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:55:20Z","timestamp":1791521720425,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["20008799"],"award-info":[{"award-number":["20008799"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1I1A3A01062573"],"award-info":[{"award-number":["2019R1I1A3A01062573"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jchromb.2023.123892","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T02:29:19Z","timestamp":1695781759000},"page":"123892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Establishment of an LC-MS\/MS method for quantification of lifitegrast in rabbit plasma and ocular tissues and its application to pharmacokinetic study"],"prefix":"10.1016","volume":"1229","author":[{"given":"Eunbin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunbee","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du Hyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Soo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-1087","authenticated-orcid":false,"given":"Soyoung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2023.123892_b0005","first-page":"90","article-title":"An Immune-mediated ocular surface disorder","volume":"130","author":"William Stevenson","year":"2012","journal-title":"Mech. Ophthal. Dis."},{"key":"10.1016\/j.jchromb.2023.123892_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Michael","year":"2007","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jchromb.2023.123892_b0015","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jchromb.2023.123892_b0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/jop.2017.0106","article-title":"Ocular distribution and pharmacokinetics of lifitegrast in pigmented rabbits and mass balance in beagle dogs","volume":"34","author":"Chung","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123892_b0025","doi-asserted-by":"crossref","first-page":"S-161","DOI":"10.1016\/S1542-0124(12)70246-X","article-title":"Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease","volume":"3","author":"Stern","year":"2005","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jchromb.2023.123892_b0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/jop.2016.0105","article-title":"LFA-1\/ICAM-1 interaction as a therapeutic target in dry eye disease","volume":"33","author":"Pflugfelder","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2023.123892_b0035","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1167\/iovs.09-5078","article-title":"The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs","volume":"52","author":"Murphy","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jchromb.2023.123892_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The Immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.jchromb.2023.123892_b0045","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.3390\/ijms21082674","article-title":"Modes of communication between T cells and relevance for immune responses","volume":"21","author":"Uhl","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jchromb.2023.123892_b0050","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms21082758","article-title":"A multivalent ICAM-1 binding nanoparticle which inhibits ICAM-1 and LFA-1 interaction represents a new tool for the investigation of autoimmune-mediated dry eye","volume":"21","author":"Hsueh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2023.123892_b0055","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0039-6257(00)00203-4","article-title":"The ocular surface and tear film and their dysfunction in dry eye disease","volume":"45","author":"Rolando","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jchromb.2023.123892_b0060","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamaophthalmol.2021.3943","article-title":"Efficacy of lifitegrast ophthalmic solution, 5.0%, in patients with moderate to severe dry eye disease: A post hoc analysis of 2 randomized clinical trials","volume":"139","author":"Holland","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jchromb.2023.123892_b0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jchromb.2023.123892_b0070","unstructured":"FDA Approves Xiidra, 2016."},{"key":"10.1016\/j.jchromb.2023.123892_b0075","article-title":"Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: overview of clinical trial program","author":"Clara","year":"2019","journal-title":"J Pharm Pharm Sc"},{"key":"10.1016\/j.jchromb.2023.123892_b0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jchromb.2023.123892_b0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0976-500X.195920","article-title":"Lifitegrast: A novel drug for treatment of dry eye disease","volume":"7","author":"Abidi","year":"2016","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.jchromb.2023.123892_b0090","article-title":"Lifitegrast: a novel drug for patients with dry eye disease","volume":"11","author":"Haber","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"issue":"1","key":"10.1016\/j.jchromb.2023.123892_b0095","doi-asserted-by":"crossref","DOI":"10.26420\/austinjanalpharmchem.2022.1140","article-title":"A validated method developed for estimation of lifitegrast in bulk and pharmaceutical dosage form by UV-spectrophotometer and RP-HPLC","volume":"9","author":"S","year":"2022","journal-title":"Austin J Anal Pharm Chem"},{"issue":"13","key":"10.1016\/j.jchromb.2023.123892_b0100","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/molecules25133047","article-title":"Compensate for or minimize matrix effects? Strategies for overcoming matrix effects in liquid chromatography-mass spectrometry technique: a tutorial review","volume":"25","author":"Cortese","year":"2020","journal-title":"Molecules"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:11:42Z","timestamp":1761606702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"alternative-id":["S1570023223003021"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123892","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of an LC-MS\/MS method for quantification of lifitegrast in rabbit plasma and ocular tissues and its application to pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123892"}}